Aralez Pharmaceuticals

About:

Aralez Pharmaceuticals is a global specialty pharmaceutical company.

Top Investors: Deerfield, Novelion Therapeutics, JW Asset Management, Broadfin Capital

Description:

Aralez Pharmaceuticals operates as a pharmaceutical company. The Company focuses on acquiring, developing, and commercializing products primarily in cardiovascular, pain, and other specialty areas. Aralez Pharmaceuticals serves customers worldwide.

Total Funding Amount:

$350M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Brooklyn, New York, United States

Founded Date:

1996-01-01

Contact Email:

info(AT)aralez.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2015-06-08

IPO Status:

Public

Industries: